Abstract
1. Helodermin, helospectin I and helospectin II, peptides recently isolated from the salivary gland venom of Heloderma suspectum, were compared to vasoactive intestinal peptide (VIP) with respect to effects on systemic blood pressure and on isolated femoral arteries in the rat. 2. They all reduced blood pressure in a dose-dependent manner; helodermin was less effective than VIP. However, at doses higher than 1 nmol kg-1 all four peptides reduced blood pressure to about the same extent. 3. The half-life of the hypotensive effect of VIP was longer than that of helodermin and the helospectins. 4. VIP and helodermin were equally potent in relaxing femoral arteries precontracted with phenylephrine or prostaglandin F2 alpha. 5. Helospectin I and II relaxed phenylephrine-contracted vessels to the same extent as VIP but with a lower potency. 6. Addition of VIP 1 microM to preparations exposed to helodermin 1 microM or to either of the helospectins did not produce a further relaxation. 7. The findings indicate that VIP, helodermin and helospectin I and II have a similar profile of action and therefore may act on a common receptor.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bjartell A., Persson P., Absood A., Sundler F., Håkanson R. Helodermin-like peptides in noradrenaline cells of adrenal medulla. Regul Pept. 1989 Aug;26(1):27–34. doi: 10.1016/0167-0115(89)90101-8. [DOI] [PubMed] [Google Scholar]
- Grunditz T., Persson P., Håkanson R., Absood A., Böttcher G., Rerup C., Sundler F. Helodermin-like peptides in thyroid C cells: stimulation of thyroid hormone secretion and suppression of calcium incorporation into bone. Proc Natl Acad Sci U S A. 1989 Feb;86(4):1357–1361. doi: 10.1073/pnas.86.4.1357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hoshino M., Yanaihara C., Hong Y. M., Kishida S., Katsumaru Y., Vandermeers A., Vandermeers-Piret M. C., Robberecht P., Christophe J., Yanaihara N. Primary structure of helodermin, a VIP-secretin-like peptide isolated from Gila monster venom. FEBS Lett. 1984 Dec 10;178(2):233–239. doi: 10.1016/0014-5793(84)80607-9. [DOI] [PubMed] [Google Scholar]
- Högestätt E. D., Andersson K. E., Edvinsson L. Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol Scand. 1983 Jan;117(1):49–61. doi: 10.1111/j.1748-1716.1983.tb07178.x. [DOI] [PubMed] [Google Scholar]
- Konturek S. J., Yanaihara N., Pawlik W., Jaworek J., Szewczyk K. Comparison of helodermin, VIP and PHI in pancreatic secretion and blood flow in dogs. Regul Pept. 1989 Feb;24(2):155–166. doi: 10.1016/0167-0115(89)90234-6. [DOI] [PubMed] [Google Scholar]
- Naruse S., Yasui A., Kishida S., Kadowaki M., Hoshino M., Ozaki T., Robberecht P., Christophe J., Yanaihara C., Yanaihara N. Helodermin has a VIP-like effect upon canine blood flow. Peptides. 1986;7 (Suppl 1):237–240. doi: 10.1016/0196-9781(86)90192-0. [DOI] [PubMed] [Google Scholar]
- Parker D. S., Raufman J. P., O'Donohue T. L., Bledsoe M., Yoshida H., Pisano J. J. Amino acid sequences of helospectins, new members of the glucagon superfamily, found in Gila monster venom. J Biol Chem. 1984 Oct 10;259(19):11751–11755. [PubMed] [Google Scholar]
- Robberecht P., Waelbroeck M., de Neef P., Camus J. C., Vandermeers A., Vandermeers-Piret M. C., Christophe J. Specific labelling by [125I]helodermin of high-affinity VIP receptors in rat liver membranes. FEBS Lett. 1984 Jun 25;172(1):55–58. doi: 10.1016/0014-5793(84)80872-8. [DOI] [PubMed] [Google Scholar]
- Sundler F., Christophe J., Robberecht P., Yanaihara N., Yanaihara C., Grunditz T., Håkanson R. Is helodermin produced by medullary thyroid carcinoma cells and normal C-cells? Immunocytochemical evidence. Regul Pept. 1988 Jan;20(1):83–89. doi: 10.1016/0167-0115(88)90060-2. [DOI] [PubMed] [Google Scholar]
- Vandermeers A., Vandermeers-Piret M. C., Robberecht P., Waelbroeck M., Dehaye J. P., Winand J., Christophe J. Purification of a novel pancreatic secretory factor (PSF) and a novel peptide with VIP- and secretin-like properties (helodermin) from Gila monster venom. FEBS Lett. 1984 Jan 30;166(2):273–276. doi: 10.1016/0014-5793(84)80094-0. [DOI] [PubMed] [Google Scholar]